NAPLEX (North American Pharmacist Licensure Examination) Practice Exam 2026 - Free NAPLEX Practice Questions and Study Guide

Get more with Examzify Plus

Remove ads, unlock favorites, save progress, and access premium tools across devices.

FavoritesSave progressAd-free
From $9.99Learn more
Session length

1 / 2600

What is the target dose for Sacubitril/Valsartan (Entresto)?

200 mg BID

Sacubitril/valsartan (Entresto) is a combination medication used in the treatment of heart failure with reduced ejection fraction. The target dose for Sacubitril/Valsartan is 200 mg twice daily. This dose has been shown in clinical trials to provide the most benefit in terms of reducing cardiovascular events and improving outcomes in patients with heart failure. Therefore, option A, 200 mg BID, is the correct answer.

Get further explanation with Examzify DeepDiveBeta

100 mg BID

150 mg BID

50 mg BID

Next Question
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy